WC
NTUS

Weil Company’s Natus Medical Inc NTUS Stock Holding History

Weil Company’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,440
Closed -$141K – 370
2019
Q3 		$141K Buy
+4,440
New +$129K 0.1% 113
2019
Q1 		– Sell
-5,882
Closed -$200K – 106
2018
Q4 		$200K Buy
+5,882
New +$191K 0.18% 94

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Weil Company's NTUS Position: Q4 2019 in Review

Weil Company sold out of Natus Medical Inc (NTUS) in Q4 2019, closing a stake of 4,440 shares — an estimated $141K sold.

Weil Company first reported a position in NTUS in Q4 2018 and held it in 2 quarters. The position peaked at $200K in Q4 2018. 172 funds tracked by Wall St. Rank hold NTUS as of Q4 2019.

  • Weil Company reported no remaining Natus Medical Inc position as of Q4 2019 after selling out during the quarter.
  • Weil Company sold 4,440 Natus Medical Inc shares in Q4 2019, an estimated $141K.
  • Weil Company first reported a position in Natus Medical Inc in Q4 2018 and held it in 2 quarters.
  • Weil Company's Natus Medical Inc position peaked at $200K in Q4 2018.
  • 172 funds tracked by Wall St. Rank held Natus Medical Inc as of Q4 2019.

Based on Weil Company's 13F filing for Q4 2019, filed 13 Feb 2020.